Skip to main content

Want a detailed portfolio tracker?

Pasithea Therapeutics (KTTA) P/E (2024 - 2026)

Pasithea Therapeutics (KTTA) P/E from Jan 2, 2024 to Jul 21, 2026. The TTM Pasithea Therapeutics (KTTA) P/E is -0.31. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Pasithea Therapeutics (KTTA)

YearP/EChange
2026-0.31-35.77%
2025-0.48-25.41%
2024-0.65N/A

Comparison Pasithea Therapeutics (KTTA) P/E with competitors

Pasithea Therapeutics (KTTA) P/E is -0.31.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.55%
NBYStablecoin Development Corp0.00-101.38%
ENLVEnlivex Ltd0.07-124.03%
FGENFibroGen Inc0.24-177.11%
CHRSCoherus Biosciences Inc0.85-372.59%
FBIOFortress Biotech Inc0.95-404.87%
ORMPOramed Pharmaceuticals Inc1.50-582.85%
AGENAgenus Inc3.01-1066.82%
INVAInnoviva Inc3.15-1113.21%
VXRTVaxart Inc3.55-1240.33%
CRMDCorMedix Inc3.63-1265.61%
CVACCureVac N.V.4.45-1528.14%
GLPGGalapagos NV4.86-1660.89%
SRPTSarepta Therapeutics Inc4.88-1668.34%
ABEOAbeona Therapeutics Inc5.39-1830.70%
ABUSArbutus Biopharma Corp5.60-1897.56%
ZVRAZevra Therapeutics Inc5.89-1991.24%
SPROSpero Therapeutics Inc6.23-2100.85%
CGENCompugen Ltd6.31-2128.32%
RIGLRigel Pharmaceuticals6.87-2307.61%
SLXNSilexion Therapeutics Corp7.30-2443.82%
OMEROmeros Corporation9.26-3074.32%
AUPHAurinia Pharmaceuticals Inc9.58-3179.11%
PLXProtalix BioTherapeutics Inc10.89-3598.67%
ACADAcadia Pharmaceuticals Inc11.73-3867.73%
TBPHTheravance Biopharma Inc12.26-4039.15%
ADMAAdma Biologics Inc12.42-4089.26%
HRMYHarmony Biosciences Holdings Inc13.82-4539.67%
SABSSAB Biotherapeutics Inc14.14-4641.18%
NAGENiagen Bioscience Inc14.82-4860.25%
INCYIncyte Corp15.82-5182.92%
REGNRegeneron Pharmaceuticals Inc15.86-5193.87%
PBYIPuma Biotechnology Inc17.32-5662.59%
CPRXCatalyst Pharmaceuticals Inc17.44-5702.29%
EXELExelixis Inc17.54-5734.00%
TGTXTG Therapeutics Inc18.97-6192.75%
MDXGMimedx Group Inc20.55-6702.40%
XOMAXOMA Royalty Corp22.87-7448.58%
ARGXArgen X SE24.30-7905.82%
CTMXCytomX Therapeutics Inc24.82-8073.87%
XOMAOXOMA Royalty Corp25.34-8242.11%
HALOHalozyme Therapeutics Inc25.62-8331.71%
XOMAPXOMA Royalty Corp25.67-8346.62%
VRTXVertex Pharmaceuticals Inc27.99-9093.41%
RPRXRoyalty Pharma plc - Class A28.69-9315.98%
SLNOSoleno Therapeutics Inc29.02-9421.28%
ASNDAscendis Pharma A/S30.09-9765.09%
LGNDLigand Pharmaceuticals Inc - Class B37.91-12279.37%
APLSApellis Pharmaceuticals Inc39.02-12635.71%
BMRNBiomarin Pharmaceutical Inc42.21-13660.71%
KRYSKrystal Biotech Inc45.34-14666.76%
ONCBeiGene Ltd69.54-22440.13%
PHARPharming Group N.V.75.03-24202.25%
TECHBio-Techne Corp101.96-32854.52%
VCELVericel Corp109.92-35412.65%
ALNYAlnylam Pharmaceuticals Inc117.96-37996.74%
GMABGenmab140.29-45168.95%
TLXTelix Pharmaceuticals Ltd162.15-52192.22%
CORTCorcept Therapeutics Inc212.86-68481.30%